Jun. 18, 2026 – Americans for Lower Drug Prices praised Louisiana Gov. Jeff Landry for signing SB 401 into law, a bill that creates a Prescription Drug Affordability Board (PDAB), demands drugmaker accountability, and shines a light on high drug prices. In May, the legislation passed the Senate unanimously and the House by an overwhelming margin (88-7). The legislation does not impose price controls, set reimbursement limits, or restrict patient access to medications.
The following statement is from ALDP co-founders Michael Glassner and Jason Young:
“Gov. Landry has shown strong leadership on tackling high health care costs, demanding accountability from the pharmaceutical industry and bringing needed scrutiny to high drug prices.
“President Trump has helped elevate the issue of prescription drug costs nationally. Louisiana is now showing that states can take practical, bipartisan steps to improve transparency and accountability.
“SB 401 does something straightforward and necessary: it requires drug manufacturers to explain, in a detailed, written, and accountable way, why their prices are what they are – prices that they set and that everyone else in the healthcare system must respond to, including more than 300,000 uninsured Louisianans.
“This is a transparency measure – a smoke alarm, not a sprinkler. It does not set prices, limit access, or impose reimbursement restrictions. It simply helps policymakers better understand what Louisiana patients, taxpayers, employers, and small businesses face and provides much-needed information about one of the fastest-growing pressures in healthcare and on the state budget.
“SB 401 passed the Senate unanimously and the House by an overwhelming bipartisan margin because lawmakers recognized a simple reality: patients deserve answers about how prescription drug prices are set.
“ALDP is grateful to Gov. Landry and Senators Kirk Talbot and Adam Bass for their leadership against ever-increasing health care costs, and drug prices in particular.”
SB 401 is part of a four-bill package that ALDP worked on this session. The other bills signed by Gov. Landry are SB 387, HB 870, and HB 1236.
About Americans for Lower Drug Prices
Americans for Lower Drug Prices (ALDP) is a bipartisan 501(c)(4) advocacy organization working to lower drug prices and enact Prescription Drug Affordability Boards at the state level. PDABs address the root cause of unaffordable medications: manufacturers’ unchecked pricing power. ALDP’s commonsense advocacy is focused on veterans, seniors, people living in rural communities, people with disabilities, and Americans who are either uninsured or underinsured, as high drug prices disproportionately harm these groups.
For more information and to hear directly from patients about their prescription drug cost struggles, visit LowerRxPrices.org.